DERAMIOCEL
US stocks: Capricor shares 77% soar as potential FDA lifeline revives Duchenne drug hopesCapricor Therapeutics shares surged significantly after the FDA agreed to review new drug data. The company had faced setbacks last month r...
CAPR stock price: Why is Capricor Therapeutics stock surging over 293% today?CAPR stock: Capricor Therapeutics' stock soared over 293% after its Phase 3 HOPE-3 trial for Duchenne muscular dystrophy showed promising r...
- Load More